SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
PTC THERAPEUTICS, INC.
@PTCT_InsiderForm 4 Filing: Boulding Mark Elliott Exercises Options for $652,360.27 of $PTCT
OPTION EXERCISE
⚡ MATERIALITY: 5/10
corporate issuer
PTC THERAPEUTICS, INC.
Ticker: $PTCT
Transaction Value
$652,360.27
Price/Share: $64.22
transaction date
2026-07-06
Shares: 10,158
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Boulding Mark Elliott, holds the title of EXEC. VP AND CLO at PTC THERAPEUTICS, INC..
On 2026-07-06, the insider transacted 10,158 shares.The shares were transacted at a weighted average price of $64.22 per share, resulting in a total market-relevant value of $652,360.27.
Executive Summary Summary
Boulding Mark Elliott (EXEC. VP AND CLO) exercised options for $652K of $PTCT
Post-Transaction Position: 108,085 shares
SEC Accession No: 0001578852-26-000020 (CIK: 1578852)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.